Dec 08, 2022
Pre-announcement: EJP on Rare Diseases (RD) Call in 2023
The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with expected impact to use the results in the future for benefit of patients.
Topic: Natural History studies addressing unmet needs in Rare Diseases
The objective of this call is to conduct efficient, innovative and high-quality natural history studies which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy.
Research proposals should cover at least one of the following areas:
- Estimation of disease prevalence;
- Identification of biomarkers/companions for the diagnosis/prognosis of a RD;
- Identification of biomarkers/indicators/predictors of a rare disease or group of disorders (e.g. having the same aetiology) onset/progression (including collection of genetic, physiological, environmental data or variables….);
- Identification of relevant endpoints for future studies that include potential biomarkers, querying patient-reported outcomes (PROs) and quality-of-life measures;
- Identification of biomarkers/variables for therapeutic approaches (pharmacology, drug repurposing, gene therapy, RNA therapy, cell therapy, medical devices…).
It is possible to use cellular and animal models for validation of endpoints and biomarkers uncovered in the natural history studies where relevant.
Timeline and eligibility criteria:
- 12th of December 2022 – Call opening
- 15th of February 2023 – pre-proposal submission
- 14th of June 2023 – full-proposal submission
- DFG and BMBF funding
- Funding for transnational joint projects with min four partner from four participating countries
- maximum of six partners (eight und certain conditions)
Participating countries:
Belgium, Canada, France, Germany, Hungary*, Ireland, Israel, Italy, Lithuania, Luxembourg, Poland, Slovakia, Spain, Sweden, Switzerland, Turkey
*Decision pending
Further information:
https://www.ejprarediseases.org/joint-transnational-call-2023/
Contact at EPC:
Project Manager
NameMr Dr. Stefan Schuldt
ERA-Nets, BMBF Complementary measures
Send encrypted email via the SecureMail portal (for TUD external users only).
Visiting address:
FAL Falkenbrunnen BT-A Würzburger Straße 35
01187 Dresden